Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • sanush
    Member
    • Nov 2009
    • 14

    Tag counts for RNA seq experiment

    Hi all
    We have to design an experiment to sequence the transcriptomes of 2 different cell types to know what genes are differentially expressed.

    ABI recommends different Tag numbers (mappable reads) for different applications but they don't specify the exact (atleast approximate) mappable reads required to survey for different applications.

    So to study the differentially expressed genes in different cell types what is the recommended mappable reads or tags we need to get a good coverage.

    Thanks for the suggestions
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    Originally posted by sanush View Post
    Hi all
    We have to design an experiment to sequence the transcriptomes of 2 different cell types to know what genes are differentially expressed.

    ABI recommends different Tag numbers (mappable reads) for different applications but they don't specify the exact (atleast approximate) mappable reads required to survey for different applications.

    So to study the differentially expressed genes in different cell types what is the recommended mappable reads or tags we need to get a good coverage.

    Thanks for the suggestions
    In case you missed my answer in the other thread you started:



    Here is what I posted:

    Brian Coullahan, Lifetech Application Specialist, gave a talk at the 2009 SOLiD Summit in September. He recommended:

    SREK 10-20 million mapped reads
    SWTAK 10-100 million
    SOLiD SAGE 2-5 million
    --
    Phillip

    Comment

    • sanush
      Member
      • Nov 2009
      • 14

      #3
      Thanks Phillip
      I have that slide too, but it gives us a range 10 - 100 M. Is there any specifics like the number of mappable reads required for different applications... what difference can we see in final data with lower reads and higher reads.

      My question is should we have to aim for higher reads(90M) or around 30-40M reads, because as we go for high reads then we need to load 1 sample in multiple segments in quad slide which could increase the cost of the experiment.

      Really appreciate your suggestion

      Subu

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        Originally posted by sanush View Post
        Thanks Phillip
        I have that slide too, but it gives us a range 10 - 100 M. Is there any specifics like the number of mappable reads required for different applications... what difference can we see in final data with lower reads and higher reads.

        My question is should we have to aim for higher reads(90M) or around 30-40M reads, because as we go for high reads then we need to load 1 sample in multiple segments in quad slide which could increase the cost of the experiment.

        Really appreciate your suggestion

        Subu
        It is hard to say.
        For polyA+ RNA 30M should be plenty unless you are focused on transcripts with low relative abundance (below, say, 10 transcripts per million), I would think. For non-polyA+ RNA (eg, ribominus) for which you also need information on poly-adenylated messages--then maybe you would want to get closer to 100M because structural RNAs will occupy a large proportion of your sequence space.

        You can always add more sequence later if you don't have enough.

        --
        Phillip

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM
        • GATTACAT
          Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
          by GATTACAT
          Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
          07-01-2026, 11:43 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:26 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Working...